5.23 Webinar Feedback - Home - dnosis
Minhas atividades
- outubro 23, 2019
-
-
-
-
- julho 11, 2019
-
- julho 9, 2019
-
Fórum
5.23 Webinar Feedback
Marshall Collins, modificado 5 Anos atrás.
5.23 Webinar Feedback
Youngling Postagens: 10 Data de Entrada: 28/03/18 Postagens Recentes
00
· Lessons from your interviews were very valuable – the “rule-out” of screening in a big and important insight! Make sure to confirm due to its importance.· Strive to ask the right questions to the right peopleo Interviewees seemed they were targeted to 3 different categories: clinicians, families, clinicso It would be helpful to divide interview findings into your various groups so you can see grouped resultso Try asking this type of question next time: Do you think it is possible to come up with an objective tool that positively diagnoses autism? This will help you· Clarify the work you want to do with schools – which is obviously with older childeren· There were questions relating to the efficacy of diagnosing autism in infants, as they most likely are pre-symptomatic; currently there is no diagnosis for children who have no displayed behavioral indicators.o There are no therapies developed for infants – so who will order the test?· Ideas to explore:1) How effective is current screening for autism?2) What percentage of positive screened children are eventually diagnosed with autism?3) Why do certain children get missed in detection of autism?4) How can you detect autism in earlier stages?5) What drives the time-lag between a suspicion of Autism and a definitive diagnosis?· Team expressed they were ruling out developing a screening tool for young children. There are screenings for children in the US at 18mo and 24mo via a questionnaire. There could be a market here.· It could be worth exploring an objective solution for identifying autism, or a screening tool -- but one that is not deemed early intervention as therapies are generally used in later aged childrenDnosis GAITS Risk Feedback:· Self identified Risk: Market/Business - A clear value proposition is not yet refinedMentor Risks Dnosis:· Market/Business: Need (vs ‘want”) must be clear before you can establish if you have a compelling value proposition. The “need” is still unclear· Market/Business: If successful, it does not appear that you can protect your business currently· Clinical: What is the benefit of early intervention (with a definitive diagnosis) - something to explore further